Zhengmin Xu

Years Active: 2023-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Lu Qi, Xiangyu Pan, Xuelan Chen, Pengpeng Liu, Mei Chen, Qi Zhang, Xiaohang Hang, Minghai Tang, Dan Wen, Lunzhi Dai, Chong Chen, Yu Liu, Zhengmin Xu
COX-2/PGE2 upregulation contributes to the chromosome 17p-deleted lymphoma. Oncogenesis 12 (1) (2023)
Lu Qi, Xiangyu Pan, Xuelan Chen, Pengpeng Liu, Mei Chen, Qi Zhang, Xiaohang Hang, Minghai Tang, Dan Wen, Lunzhi Dai, Chong Chen, Yu Liu, Zhengmin Xu
COX-2/PGE2 upregulation contributes to the chromosome 17p-deleted lymphoma. Oncogenesis 12 (1) (2023)
Jun You, Jiaojiao Bian, Jian Chen, Tianqin Xia, Ailu Deng, Ming Zhang, YiChen Liao, Huling Wen, Zhengmin Xu
TNFSF15 and MIA Variant Associated with Immunotherapy and Prognostic Evaluation in Esophageal Cancer. Journal of oncology 2023 (2023)
Jun You, Jiaojiao Bian, Jian Chen, Tianqin Xia, Ailu Deng, Ming Zhang, YiChen Liao, Huling Wen, Zhengmin Xu
TNFSF15 and MIA Variant Associated with Immunotherapy and Prognostic Evaluation in Esophageal Cancer. Journal of oncology 2023 (2023)

Zhengmin Xu.css-eqlu8i{font-size:small;padding-left:4px;}